Cellf-Bio Inc.

Chantilly, VA

UEI
DQMVZJFCVNK3
CAGE
74WJ1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
25007 Cambridge Hill Terrace, Chantilly, VA 20152, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Biosphincter to treat fecal incontinence. Phase 1/2 clinical trial. Sbir phase IIB R44DK105593 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $7,220,134
Implantation of bioengineered intrinsically innervated internal anal sphincter (biosphincter) to treat fecal… R42DK105593 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $1,038,240

Quick answers

Is Cellf-Bio Inc. registered in SAM.gov?

Yes. Cellf-Bio Inc.'s SAM.gov registration is active through January 14, 2027.

What is Cellf-Bio Inc.'s most recent federal award?

Cellf-Bio Inc.'s most recent federal grant award is Biosphincter to treat fecal incontinence. Phase 1/2 clinical trial. Sbir phase IIB (R44DK105593), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 23, 2015.

On GovTribe

See Cellf-Bio Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login